Tracy S. A. Underwood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tracy S. A. Underwood has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Harald Paganetti
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
3 shared publicationsHsiao-Ming Lu
A Department of Radiation Oncology , Massachusetts General Hospital, Harvard Medical School , Boston , MA , USA
3 shared publications- Mark A. Hill
University of Oxford
3 shared publications Carl Graham Rowbottom
Physics Department, Clatterbridge Cancer Centre, Liverpool, England, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
2 shared publications- Edward A. K. Smith
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
2 shared publications Georgios Georgiou
Institute of Translational Medicine, University of Liverpool, Liverpool, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
2 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1187) , 2227-2238
Upright, gantry-less treatments for particle therapy: a potential paradigm shift
Particle therapy can offer physical and biological advantages over conventional photon radiotherapy, yet its widespread adoption remains limited by the cost, scale, and complexity of the accelerators and rotating gantries involved. Upright patient positioning with fixed-beam delivery has re-emerged as a potential alternative that may simplify particle therapy systems. Here we consider upright, gantry-less particle therapy through the lens of philosopher Thomas Kuhn’s 5 criteria for scientific change: (1) simplicity, (2) scope, (3) fruitfulness, (4) consistency, and (5) accuracy. Eliminating rotating gantries stands to improve simplicity by reducing mechanical complexity, weight, and maintenance requirements. This in turn should enable more robust and modular treatment rooms. Early studies also suggest that upright positioning has broad scope: it can reproduce most beam geometries achieved using gantries and appears feasible across multiple anatomical sites. Upright treatments may be fruitful in terms of reducing capital, construction, and operational costs. They will also bring opportunities for technological innovation and potentially for improved patient throughput due to faster ingress and egress. Regarding consistency, upright treatment postures more closely match normal, everyday physiology and are often associated with greater comfort for certain patient groups. Finally, in terms of accuracy, preliminary studies suggest suitable setup reproducibility and comparable treatment planning quality. Upright particle therapy, therefore, represents a promising alternative delivery model. Further treatment-planning studies, health-economic analyses, and prospective clinical trials are warranted to determine the role of upright systems alongside or in place of gantry-based systems.
- 3 September 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1187) , 2227-2238
Open AccessUpright, gantry-less treatments for particle therapy: a potential paradigm shift
Particle therapy can offer physical and biological advantages over conventional photon radiotherapy, yet its widespread adoption remains limited by the cost, scale, and complexity of the accelerators and rotating gantries involved. Upright patient positioning with fixed-beam delivery has re-emerged as a potential alternative that may simplify particle therapy systems. Here we consider upright, gantry-less particle therapy through the lens of philosopher Thomas Kuhn’s 5 criteria for scientific change: (1) simplicity, (2) scope, (3) fruitfulness, (4) consistency, and (5) accuracy. Eliminating rotating gantries stands to improve simplicity by reducing mechanical complexity, weight, and maintenance requirements. This in turn should enable more robust and modular treatment rooms. Early studies also suggest that upright positioning has broad scope: it can reproduce most beam geometries achieved using gantries and appears feasible across multiple anatomical sites. Upright treatments may be fruitful in terms of reducing capital, construction, and operational costs. They will also bring opportunities for technological innovation and potentially for improved patient throughput due to faster ingress and egress. Regarding consistency, upright treatment postures more closely match normal, everyday physiology and are often associated with greater comfort for certain patient groups. Finally, in terms of accuracy, preliminary studies suggest suitable setup reproducibility and comparable treatment planning quality. Upright particle therapy, therefore, represents a promising alternative delivery model. Further treatment-planning studies, health-economic analyses, and prospective clinical trials are warranted to determine the role of upright systems alongside or in place of gantry-based systems.
- Open Access
- 8 May 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (10)
A low-cost, flexible, and accurate technique to study new immobilisation systems for radiotherapy and their 2D in-plane positional reproducibility and stability
Recently, there has been a resurgence of interest in upright, gantry-less radiotherapy due to its potential to reduce the costs associated with new treatment rooms and improve comfort/clinical outcomes for specific patient groups. Consequently, new patient positioning and immobilisation devices are being developed for upright and conventional radiotherapy. Before any new RT immobilisation system is implemented clinically, pre-clinical tests should be performed to verify its reproducibility and stability. Surface-guided radiotherapy (SGRT) can be used; however, commercial SGRT systems are expensive and can require complex installation and calibration procedures. Therefore, we developed a low-cost, flexible 2D in-plane displacement measurement system to support the testing and development of new immobilisation devices for RT. The method developed in this work couples ArUco markers with regular cameras positioned orthogonally on tripods to capture images in two planes. Markers fixed onto human subjects can then be used to assess the inter- and intra-fractional repeatability and stability associated with new immobilisation systems. A Python algorithm was developed to automatically detect ArUCo markers in each camera image and infer the distance between markers across multiple camera images. Contrary to most measurement systems, the proposed method does not require camera calibration, and any camera with sufficiently high image resolution and relatively low lens distortion can be used. Rigorous validation experiments, using simulated data, were performed to test the algorithm’s measurement accuracy for different marker separations and camera-to-marker distances. Accuracy validation test results show that the proposed system has a mean measurement error below 1mm. These errors are at the same order of magnitude as the commercial SGRT systems. The proposed system provides a viable low-cost solution for assessing positional repeatability and stability of new immobilisation devices during pre-clinical development. This is particularly relevant as new positioning systems are being developed for both upright and conventional supine RT treatments.
- 8 May 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (10)
Open AccessA low-cost, flexible, and accurate technique to study new immobilisation systems for radiotherapy and their 2D in-plane positional reproducibility and stability
Recently, there has been a resurgence of interest in upright, gantry-less radiotherapy due to its potential to reduce the costs associated with new treatment rooms and improve comfort/clinical outcomes for specific patient groups. Consequently, new patient positioning and immobilisation devices are being developed for upright and conventional radiotherapy. Before any new RT immobilisation system is implemented clinically, pre-clinical tests should be performed to verify its reproducibility and stability. Surface-guided radiotherapy (SGRT) can be used; however, commercial SGRT systems are expensive and can require complex installation and calibration procedures. Therefore, we developed a low-cost, flexible 2D in-plane displacement measurement system to support the testing and development of new immobilisation devices for RT. The method developed in this work couples ArUco markers with regular cameras positioned orthogonally on tripods to capture images in two planes. Markers fixed onto human subjects can then be used to assess the inter- and intra-fractional repeatability and stability associated with new immobilisation systems. A Python algorithm was developed to automatically detect ArUCo markers in each camera image and infer the distance between markers across multiple camera images. Contrary to most measurement systems, the proposed method does not require camera calibration, and any camera with sufficiently high image resolution and relatively low lens distortion can be used. Rigorous validation experiments, using simulated data, were performed to test the algorithm’s measurement accuracy for different marker separations and camera-to-marker distances. Accuracy validation test results show that the proposed system has a mean measurement error below 1mm. These errors are at the same order of magnitude as the commercial SGRT systems. The proposed system provides a viable low-cost solution for assessing positional repeatability and stability of new immobilisation devices during pre-clinical development. This is particularly relevant as new positioning systems are being developed for both upright and conventional supine RT treatments.
- Open Access
- 17 December 2021
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 8 (1) , 015024
A Monte Carlo study of different LET definitions and calculation parameters for proton beam therapy
The strong in vitro evidence that proton Relative Biological Effectiveness (RBE) varies with Linear Energy Transfer (LET) has led to an interest in applying LET within treatment planning. However, there is a lack of consensus on LET definition, Monte Carlo (MC) parameters or clinical methodology. This work aims to investigate how common variations of LET definition may affect potential clinical applications. MC simulations (GATE/GEANT4) were used to calculate absorbed dose and different types of LET for a simple Spread Out Bragg Peak (SOBP) and for four clinical PBT plans covering a range of tumour sites. Variations in the following LET calculation methods were considered: (i) averaging (dose-averaged LET (LETd) & track-averaged LET); (ii) scoring (LETd to water, to medium and to mass density); (iii) particle inclusion (LETd to all protons, to primary protons and to particles); (iv) MC settings (hit type and Maximum Step Size (MSS)). LET distributions were compared using: qualitative comparison, LET Volume Histograms (LVHs), single value criteria (maximum and mean values) and optimised LET-weighted dose models. Substantial differences were found between LET values in averaging, scoring and particle type. These differences depended on the methodology, but for one patient a difference of ∼100% was observed between the maximum LETd for all particles and maximum LETd for all protons within the brainstem in the high isodose region (4 keV μm−1 and 8 keV μm−1 respectively). An RBE model using LETd including heavier ions was found to predict substantially different LET-weighted dose compared to those using other LET definitions. In conclusion, the selection of LET definition may affect the results of clinical metrics considered in treatment planning and the results of an RBE model. The authors’ advocate for the scoring of dose-averaged LET to water for primary and secondary protons using a random hit type and automated MSS.
- 17 December 2021
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 8 (1) , 015024
Open AccessA Monte Carlo study of different LET definitions and calculation parameters for proton beam therapy
The strong in vitro evidence that proton Relative Biological Effectiveness (RBE) varies with Linear Energy Transfer (LET) has led to an interest in applying LET within treatment planning. However, there is a lack of consensus on LET definition, Monte Carlo (MC) parameters or clinical methodology. This work aims to investigate how common variations of LET definition may affect potential clinical applications. MC simulations (GATE/GEANT4) were used to calculate absorbed dose and different types of LET for a simple Spread Out Bragg Peak (SOBP) and for four clinical PBT plans covering a range of tumour sites. Variations in the following LET calculation methods were considered: (i) averaging (dose-averaged LET (LETd) & track-averaged LET); (ii) scoring (LETd to water, to medium and to mass density); (iii) particle inclusion (LETd to all protons, to primary protons and to particles); (iv) MC settings (hit type and Maximum Step Size (MSS)). LET distributions were compared using: qualitative comparison, LET Volume Histograms (LVHs), single value criteria (maximum and mean values) and optimised LET-weighted dose models. Substantial differences were found between LET values in averaging, scoring and particle type. These differences depended on the methodology, but for one patient a difference of ∼100% was observed between the maximum LETd for all particles and maximum LETd for all protons within the brainstem in the high isodose region (4 keV μm−1 and 8 keV μm−1 respectively). An RBE model using LETd including heavier ions was found to predict substantially different LET-weighted dose compared to those using other LET definitions. In conclusion, the selection of LET definition may affect the results of clinical metrics considered in treatment planning and the results of an RBE model. The authors’ advocate for the scoring of dose-averaged LET to water for primary and secondary protons using a random hit type and automated MSS.
- Open Access
- 31 July 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (15) , 155011
Density compensated diodes for small field dosimetry: comprehensive testing and implications for design
: Purpose. In small megavoltage photon fields, the accuracies of an unmodified PTW 60017-type diode dosimeter and six diodes modified by adding airgaps of thickness 0.6–1.6 mm and diameter 3.6 mm have been comprehensively characterized experimentally and computationally. The optimally thick airgap for density compensation was determined, and detectors were micro-CT imaged to investigate differences between experimentally measured radiation responses and those predicted computationally. Methods. Detectors were tested on- and off-axis, at 5 and 15 cm depths in 6 and 15 MV fields ≥ 0.5 × 0.5 cm2. Computational studies were carried out using the EGSnrc/BEAMnrc Monte Carlo radiation transport code. Experimentally, radiation was delivered using a Varian TrueBeam linac and doses absorbed by water were measured using Gafchromic EBT3 film and ionization chambers, and compared with diode readings. Detector response was characterized via the k Q c l i n , Q m s r f c l i n , f m s r formalism, choosing a 4 × 4 cm2 reference field. Results. For the unmodified 60017 diode, the maximum error in small field doses obtained from diode readings uncorrected by k Q c l i n , Q m s r f c l i n , f m s r factors was determined as 11.9% computationally at +0.25 mm off-axis and 5 cm depth in a 15 MV 0.5 × 0.5 cm2 field, and 11.7% experimentally at −0.30 mm off-axis and 5 cm depth in the same field. A detector modified to include a 1.6 mm thick airgap performed best, with maximum computationally and experimentally determined errors of 2.2% and 4.1%. The 1.6 mm airgap deepened the modified dosimeter’s effective point of measurement by 0.5 mm. For some detectors significant differences existed between responses in small fields determined computationally and experimentally, micro-CT imaging indicating that these differences were due to within-tolerance variations in the thickness of an epoxy resin layer. Conclusions. The dosimetric performance of a 60017 diode detector was comprehensively improved throughout 6 and 15 MV small photon fields via density compensation. For this approach to work well with good detector-to-detector reproducibility, tolerances on dense component dimensions should be reduced to limit associated variations of response in small fields, or these components should be modified to have more water-like densities.
- 31 July 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (15) , 155011
Open AccessDensity compensated diodes for small field dosimetry: comprehensive testing and implications for design
: Purpose. In small megavoltage photon fields, the accuracies of an unmodified PTW 60017-type diode dosimeter and six diodes modified by adding airgaps of thickness 0.6–1.6 mm and diameter 3.6 mm have been comprehensively characterized experimentally and computationally. The optimally thick airgap for density compensation was determined, and detectors were micro-CT imaged to investigate differences between experimentally measured radiation responses and those predicted computationally. Methods. Detectors were tested on- and off-axis, at 5 and 15 cm depths in 6 and 15 MV fields ≥ 0.5 × 0.5 cm2. Computational studies were carried out using the EGSnrc/BEAMnrc Monte Carlo radiation transport code. Experimentally, radiation was delivered using a Varian TrueBeam linac and doses absorbed by water were measured using Gafchromic EBT3 film and ionization chambers, and compared with diode readings. Detector response was characterized via the k Q c l i n , Q m s r f c l i n , f m s r formalism, choosing a 4 × 4 cm2 reference field. Results. For the unmodified 60017 diode, the maximum error in small field doses obtained from diode readings uncorrected by k Q c l i n , Q m s r f c l i n , f m s r factors was determined as 11.9% computationally at +0.25 mm off-axis and 5 cm depth in a 15 MV 0.5 × 0.5 cm2 field, and 11.7% experimentally at −0.30 mm off-axis and 5 cm depth in the same field. A detector modified to include a 1.6 mm thick airgap performed best, with maximum computationally and experimentally determined errors of 2.2% and 4.1%. The 1.6 mm airgap deepened the modified dosimeter’s effective point of measurement by 0.5 mm. For some detectors significant differences existed between responses in small fields determined computationally and experimentally, micro-CT imaging indicating that these differences were due to within-tolerance variations in the thickness of an epoxy resin layer. Conclusions. The dosimetric performance of a 60017 diode detector was comprehensively improved throughout 6 and 15 MV small photon fields via density compensation. For this approach to work well with good detector-to-detector reproducibility, tolerances on dense component dimensions should be reduced to limit associated variations of response in small fields, or these components should be modified to have more water-like densities.
- Open Access
- 27 December 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
In Silico Models of DNA Damage and Repair in Proton Treatment Planning: A Proof of Concept
There is strong in vitro cell survival evidence that the relative biological effectiveness (RBE) of protons is variable, with dependence on factors such as linear energy transfer (LET) and dose. This is coupled with the growing in vivo evidence, from post-treatment image change analysis, of a variable RBE. Despite this, a constant RBE of 1.1 is still applied as a standard in proton therapy. However, there is a building clinical interest in incorporating a variable RBE. Recently, correlations summarising Monte Carlo-based mechanistic models of DNA damage and repair with absorbed dose and LET have been published as the Manchester mechanistic (MM) model. These correlations offer an alternative path to variable RBE compared to the more standard phenomenological models. In this proof of concept work, these correlations have been extended to acquire RBE-weighted dose distributions and calculated, along with other RBE models, on a treatment plan. The phenomenological and mechanistic models for RBE have been shown to produce comparable results with some differences in magnitude and relative distribution. The mechanistic model found a large RBE for misrepair, which phenomenological models are unable to do. The potential of the MM model to predict multiple endpoints presents a clear advantage over phenomenological models.
- 27 December 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Open AccessIn Silico Models of DNA Damage and Repair in Proton Treatment Planning: A Proof of Concept
There is strong in vitro cell survival evidence that the relative biological effectiveness (RBE) of protons is variable, with dependence on factors such as linear energy transfer (LET) and dose. This is coupled with the growing in vivo evidence, from post-treatment image change analysis, of a variable RBE. Despite this, a constant RBE of 1.1 is still applied as a standard in proton therapy. However, there is a building clinical interest in incorporating a variable RBE. Recently, correlations summarising Monte Carlo-based mechanistic models of DNA damage and repair with absorbed dose and LET have been published as the Manchester mechanistic (MM) model. These correlations offer an alternative path to variable RBE compared to the more standard phenomenological models. In this proof of concept work, these correlations have been extended to acquire RBE-weighted dose distributions and calculated, along with other RBE models, on a treatment plan. The phenomenological and mechanistic models for RBE have been shown to produce comparable results with some differences in magnitude and relative distribution. The mechanistic model found a large RBE for misrepair, which phenomenological models are unable to do. The potential of the MM model to predict multiple endpoints presents a clear advantage over phenomenological models.
- 1 October 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (19) , 198002
Reply to comment on ‘origins of the changing detector response in small megavoltage photon radiation fields’
Andreo and Benmakhlouf (2017 Phys. Med. Biol . 62 1518–32) have disputed a finding of Scott et al (2012 Phys. Med. Biol . 57 4461–76) that the variation with field-size of the response of small ion chambers and solid-state dosimeters in small megavoltage photon radiation fields can largely be attributed to density. Further evidence for this finding was provided by Fenwick et al (2018 Phys. Med. Biol . 63 125003), but Andreo and Benmakhlouf (2018 Phys. Med. Biol . 63 125003) have now challenged the methodology used in that study. Specifically, Andreo and Benmakhlouf suggest that mass stopping-powers of fictitious materials used in Monte Carlo radiation transport calculations should be adjusted with material density according to the polarization effect, as if the materials were real and created by compressing other real materials. In this reply, we observe that fictitious materials are not real, and therefore their densities, mass stopping-powers and microscopic radiation interaction cross-sections can be freely and independently chosen to provide the clearest answers to the questions being studied. And we note that the key role played by density in small field detector response was further confirmed by our group back in 2013, using fictitious materials in which mass stopping-powers were adjusted with density, as preferred by Andreo and Benmakhlouf, as well as being held fixed, with very similar results being obtained in both circumstances (Underwood et al 2013a Med. Phys . 40 082102).
- 1 October 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (19) , 198002
Reply to comment on ‘origins of the changing detector response in small megavoltage photon radiation fields’
Andreo and Benmakhlouf (2017 Phys. Med. Biol . 62 1518–32) have disputed a finding of Scott et al (2012 Phys. Med. Biol . 57 4461–76) that the variation with field-size of the response of small ion chambers and solid-state dosimeters in small megavoltage photon radiation fields can largely be attributed to density. Further evidence for this finding was provided by Fenwick et al (2018 Phys. Med. Biol . 63 125003), but Andreo and Benmakhlouf (2018 Phys. Med. Biol . 63 125003) have now challenged the methodology used in that study. Specifically, Andreo and Benmakhlouf suggest that mass stopping-powers of fictitious materials used in Monte Carlo radiation transport calculations should be adjusted with material density according to the polarization effect, as if the materials were real and created by compressing other real materials. In this reply, we observe that fictitious materials are not real, and therefore their densities, mass stopping-powers and microscopic radiation interaction cross-sections can be freely and independently chosen to provide the clearest answers to the questions being studied. And we note that the key role played by density in small field detector response was further confirmed by our group back in 2013, using fictitious materials in which mass stopping-powers were adjusted with density, as preferred by Andreo and Benmakhlouf, as well as being held fixed, with very similar results being obtained in both circumstances (Underwood et al 2013a Med. Phys . 40 082102).
- 1 July 2018
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 92 (1093) , 20180004
Proton relative biological effectiveness (RBE): a multiscale problem
Proton radiotherapy is undergoing rapid expansion both within the UK and internationally, but significant challenges still need to be overcome if maximum benefit is to be realised from this technique. One major limitation is the persistent uncertainty in proton relative biological effectiveness (RBE). While RBE values are needed to link proton radiotherapy to our existing experience with photon radiotherapy, RBE remains poorly understood and is typically incorporated as a constant dose scaling factor of 1.1 in clinical plans. This is in contrast to extensive experimental evidence indicating that RBE is a function of dose, tissue type, and proton linear energy transfer, among other parameters. In this article, we discuss the challenges associated with obtaining clinically relevant values for proton RBE through commonly-used assays, and highlight the wide range of other experimental end points which can inform our understanding of RBE. We propose that accurate and robust optimization of proton radiotherapy ultimately requires a multiscale understanding of RBE, integrating subcellular, cellular, and patient-level processes.
- 1 July 2018
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 92 (1093) , 20180004
Proton relative biological effectiveness (RBE): a multiscale problem
Proton radiotherapy is undergoing rapid expansion both within the UK and internationally, but significant challenges still need to be overcome if maximum benefit is to be realised from this technique. One major limitation is the persistent uncertainty in proton relative biological effectiveness (RBE). While RBE values are needed to link proton radiotherapy to our existing experience with photon radiotherapy, RBE remains poorly understood and is typically incorporated as a constant dose scaling factor of 1.1 in clinical plans. This is in contrast to extensive experimental evidence indicating that RBE is a function of dose, tissue type, and proton linear energy transfer, among other parameters. In this article, we discuss the challenges associated with obtaining clinically relevant values for proton RBE through commonly-used assays, and highlight the wide range of other experimental end points which can inform our understanding of RBE. We propose that accurate and robust optimization of proton radiotherapy ultimately requires a multiscale understanding of RBE, integrating subcellular, cellular, and patient-level processes.
- 1 July 2018
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 101 (4) , 809-819
Asymptomatic Late-phase Radiographic Changes Among Chest-Wall Patients Are Associated With a Proton RBE Exceeding 1.1
- 1 July 2018
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 101 (4) , 809-819
Asymptomatic Late-phase Radiographic Changes Among Chest-Wall Patients Are Associated With a Proton RBE Exceeding 1.1
- 1 June 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (12) , 125003
Origins of the changing detector response in small megavoltage photon radiation fields
Differences in detector response between measured small fields, f clin , and wider reference fields, f msr , can be overcome by using correction factors or by designing detectors with field-size invariant responses. The changing response in small fields is caused by perturbations of the electron fluence within the detector sensitive volume. For solid-state detectors, it has recently been suggested that these perturbations might be caused by the non-water-equivalent effective atomic numbers Z of detector materials, rather than by their non-water-like densities. Using the EGSnrc Monte Carlo code we have analyzed the response of a PTW 60017 diode detector in a 6 MV beam, calculating the correction factor from computed doses absorbed by water and by the detector sensitive volume in 0.5 × 0.5 and 4 × 4 cm 2 fields. In addition to the ‘real’ detector, fully modelled according to the manufacturer’s blue-prints, we calculated doses and factors for a ‘ Z → water’ detector variant in which mass stopping-powers and microscopic interaction coefficients were set to those of water while preserving real material densities, and for a ‘density → 1’ variant in which densities were set to 1 g cm −3 , leaving mass stopping-powers and interaction coefficients at real levels. equalled 0.910 ± 0.005 (2 standard deviations) for the real detector, was insignificantly different at 0.912 ± 0.005 for the ‘ Z → H 2 O’ variant, but equalled 1.012 ± 0.006 for the ‘density → 1’ variant. For the 60017 diode in a 6 MV beam, then, was determined primarily by the detector’s density rather than its atomic composition. Further calculations showed this remained the case in a 15 MV beam. Interestingly, the sensitive volume electron fluence was perturbed more by detector atomic composition than by density; however, the density-dependent perturbation varied with field-size, whereas the Z-dependent perturbation was relatively constant, little affecting .
- 1 June 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (12) , 125003
Origins of the changing detector response in small megavoltage photon radiation fields
Differences in detector response between measured small fields, f clin , and wider reference fields, f msr , can be overcome by using correction factors or by designing detectors with field-size invariant responses. The changing response in small fields is caused by perturbations of the electron fluence within the detector sensitive volume. For solid-state detectors, it has recently been suggested that these perturbations might be caused by the non-water-equivalent effective atomic numbers Z of detector materials, rather than by their non-water-like densities. Using the EGSnrc Monte Carlo code we have analyzed the response of a PTW 60017 diode detector in a 6 MV beam, calculating the correction factor from computed doses absorbed by water and by the detector sensitive volume in 0.5 × 0.5 and 4 × 4 cm 2 fields. In addition to the ‘real’ detector, fully modelled according to the manufacturer’s blue-prints, we calculated doses and factors for a ‘ Z → water’ detector variant in which mass stopping-powers and microscopic interaction coefficients were set to those of water while preserving real material densities, and for a ‘density → 1’ variant in which densities were set to 1 g cm −3 , leaving mass stopping-powers and interaction coefficients at real levels. equalled 0.910 ± 0.005 (2 standard deviations) for the real detector, was insignificantly different at 0.912 ± 0.005 for the ‘ Z → H 2 O’ variant, but equalled 1.012 ± 0.006 for the ‘density → 1’ variant. For the 60017 diode in a 6 MV beam, then, was determined primarily by the detector’s density rather than its atomic composition. Further calculations showed this remained the case in a 15 MV beam. Interestingly, the sensitive volume electron fluence was perturbed more by detector atomic composition than by density; however, the density-dependent perturbation varied with field-size, whereas the Z-dependent perturbation was relatively constant, little affecting .
- 28 March 2017
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 62 (8) , 3237-3249
Comparing stochastic proton interactions simulated using TOPAS-nBio to experimental data from fluorescent nuclear track detectors
Whilst Monte Carlo (MC) simulations of proton energy deposition have been well-validated at the macroscopic level, their microscopic validation remains lacking. Equally, no gold-standard yet exists for experimental metrology of individual proton tracks. In this work we compare the distributions of stochastic proton interactions simulated using the TOPAS-nBio MC platform against confocal microscope data for Al 2 O 3 :C,Mg fluorescent nuclear track detectors (FNTDs). We irradiated 8 × 4 × 0.5 mm 3 FNTD chips inside a water phantom, positioned at seven positions along a pristine proton Bragg peak with a range in water of 12 cm. MC simulations were implemented in two stages: (1) using TOPAS to model the beam properties within a water phantom and (2) using TOPAS-nBio with Geant4-DNA physics to score particle interactions through a water surrogate of Al 2 O 3 :C,Mg. The measured median track integrated brightness (IB) was observed to be strongly correlated to both (i) voxelized track-averaged linear energy transfer (LET) and (ii) frequency mean microdosimetric lineal energy, y F ¯ , both simulated in pure water. Histograms of FNTD track IB were compared against TOPAS-nBio histograms of the number of terminal electrons per proton, scored in water with mass-density scaled to mimic Al 2 O 3 :C,Mg. Trends between exposure depths observed in TOPAS-nBio simulations were experimentally replicated in the study of FNTD track IB. Our results represent an important first step towards the experimental validation of MC simulations on the sub-cellular scale and suggest that FNTDs can enable experimental study of the microdosimetric properties of individual proton tracks.
- 28 March 2017
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 62 (8) , 3237-3249
Comparing stochastic proton interactions simulated using TOPAS-nBio to experimental data from fluorescent nuclear track detectors
Whilst Monte Carlo (MC) simulations of proton energy deposition have been well-validated at the macroscopic level, their microscopic validation remains lacking. Equally, no gold-standard yet exists for experimental metrology of individual proton tracks. In this work we compare the distributions of stochastic proton interactions simulated using the TOPAS-nBio MC platform against confocal microscope data for Al 2 O 3 :C,Mg fluorescent nuclear track detectors (FNTDs). We irradiated 8 × 4 × 0.5 mm 3 FNTD chips inside a water phantom, positioned at seven positions along a pristine proton Bragg peak with a range in water of 12 cm. MC simulations were implemented in two stages: (1) using TOPAS to model the beam properties within a water phantom and (2) using TOPAS-nBio with Geant4-DNA physics to score particle interactions through a water surrogate of Al 2 O 3 :C,Mg. The measured median track integrated brightness (IB) was observed to be strongly correlated to both (i) voxelized track-averaged linear energy transfer (LET) and (ii) frequency mean microdosimetric lineal energy, y F ¯ , both simulated in pure water. Histograms of FNTD track IB were compared against TOPAS-nBio histograms of the number of terminal electrons per proton, scored in water with mass-density scaled to mimic Al 2 O 3 :C,Mg. Trends between exposure depths observed in TOPAS-nBio simulations were experimentally replicated in the study of FNTD track IB. Our results represent an important first step towards the experimental validation of MC simulations on the sub-cellular scale and suggest that FNTDs can enable experimental study of the microdosimetric properties of individual proton tracks.